EUVIMEDEUVIMED entdecken
Open Access

Midterm Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Bicuspid Aortic Valve Stenosis

Stephan Nienaber iD, Katharina Krabichler iD, David Fahlbusch iD, Victor Mauri iD, Jan Althoff iD, Samuel Lee iD, Jonathan Curio iD, Henning Guthoff iD, Karl Finke iD, Alexander Hof iD, Elmar Kuhn iD, Richard J Nies iD und 4 weitere

Journal of the American Heart Association · 07.07.2026 · 15 (13)

DOI: 10.1161/jaha.125.047634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 07.07.2026. Verfasst von Stephan Nienaber und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Heart Center Cologne, Faculty of Medicine and University Hospital University of Cologne Cologne Germany. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Bicuspid Aortic Valve Disease, Aortic Valve Stenosis, Echocardiography. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Outcomes >2 years after transcatheter aortic valve replacement (TAVR) for bicuspid aortic valves (BAV) are scarce, and differences between balloon‐expandable transcatheter heart valves (THVs) and self‐expandable (SE‐THVs) are not yet well established.

Methods

This study aims to report midterm outcomes after TAVR in patients with BAV and includes 92 patients undergoing TAVR for BAV stenosis at the University Hospital Cologne between 2018 and 2023. The primary outcomes were all‐cause death, cardiovascular death, and stroke over a mean follow‐up of 2.9 years.

Results

Among 92 consecutive patients undergoing TAVR for BAV stenosis (median age: 78.8 years), the incidence of all‐cause death, cardiovascular death, and stroke was 26.1%, 18.5%, and 14.1%, respectively, at 2.9 years, with no differences between balloon‐expandable THVs and SE‐THVs. Pacemaker implantation tended to be more frequent in the SE‐THV group. Periprocedural complications were rare, as reflected by a high Valve Academic Research Consortium‐3 technical success rate of 96.7%. Postprocedural transvalvular gradients were favorable, with SE‐THV showing lower values than balloon‐expandable THV (8.0 versus 10.5 mm Hg, P =0.007). Moderate or severe paravalvular regurgitation was uncommon, with no differences between groups, although a trend toward more relevant paravalvular regurgitation with SE‐THV was observed.

Conclusions

TAVR for BAV is feasible with both SE‐THV and balloon‐expandable ‐THV, achieving high technical success and low complication rates. Hemodynamic differences were observed, but mortality and stroke did not differ significantly between groups. Overall outcomes remain suboptimal, highlighting the need for randomized trials comparing valve types and TAVR with surgery for patients with BAV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementBicuspid Aortic Valve DiseaseAortic Valve StenosisEchocardiographyAortic ValveHumansFemaleMaleAged, 80 and overAgedTreatment OutcomeSeverity of Illness IndexHeart Valve ProsthesisTime FactorsPostoperative ComplicationsRetrospective StudiesProsthesis DesignRisk Factors

Stichwörter der Autor:innen

TAVRaortic valve stenosisbicuspid aortic valvetranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology, Heart Center Cologne, Faculty of Medicine and University Hospital University of Cologne Cologne Germany.
  • Department of Radiology, Faculty of Medicine and University Hospital University of Cologne Cologne Germany.
  • Department of Cardiothoracic Surgery, Heart Center Cologne, Faculty of Medicine and University Hospital University of Cologne Cologne Germany.

ORCID-Profile: Stephan Nienaber, Katharina Krabichler, David Fahlbusch, Victor Mauri, Jan Althoff, Samuel Lee, Jonathan Curio, Henning Guthoff, Karl Finke, Alexander Hof, Elmar Kuhn, Richard J Nies, Merve Kural, Stephan Baldus, Hendrik Wienemann, Matti Adam

Zitieren

APA

Nienaber, S., Krabichler, K., Fahlbusch, D., Mauri, V., Althoff, J., Lee, S., Curio, J., Guthoff, H., Finke, K., Hof, A., Kuhn, E., Nies, R. J., Kural, M., Baldus, S., Wienemann, H., & Adam, M. (2026). Midterm Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Bicuspid Aortic Valve Stenosis. Journal of the American Heart Association, 15(13). https://doi.org/10.1161/jaha.125.047634

Vancouver

Nienaber S, Krabichler K, Fahlbusch D, Mauri V, Althoff J, Lee S, et al. Midterm Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Bicuspid Aortic Valve Stenosis. Journal of the American Heart Association. 2026;15(13). doi:10.1161/jaha.125.047634

BibTeX
@article{Nienaber2026,
  author = {Nienaber, Stephan and Krabichler, Katharina and Fahlbusch, David and Mauri, Victor and Althoff, Jan and Lee, Samuel and Curio, Jonathan and Guthoff, Henning and Finke, Karl and Hof, Alexander and Kuhn, Elmar and Nies, Richard J and Kural, Merve and Baldus, Stephan and Wienemann, Hendrik and Adam, Matti},
  title = {Midterm Clinical and Echocardiographic Outcomes After Transcatheter Aortic Valve Replacement in Patients With Severe Bicuspid Aortic Valve Stenosis},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {13},
  doi = {10.1161/jaha.125.047634}
}
Kostenlos starten →